234 related articles for article (PubMed ID: 22492871)
21. Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretion.
Peluso JJ; Liu X; Gawkowska A; Johnston-MacAnanny E
J Clin Endocrinol Metab; 2009 Jul; 94(7):2644-9. PubMed ID: 19417032
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA regulation of progesterone receptor in breast cancer.
Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
[TBL] [Abstract][Full Text] [Related]
23. Dynamic expression of PGRMC1 and SERBP1 in human endometrium: an implication in the human decidualization process.
Salsano S; Quiñonero A; Pérez S; Garrido Gómez T; Simón C; Dominguez F
Fertil Steril; 2017 Nov; 108(5):832-842.e1. PubMed ID: 28911927
[TBL] [Abstract][Full Text] [Related]
24. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
Tian X; Xu L; Wang P
Int J Clin Exp Pathol; 2015; 8(5):4933-42. PubMed ID: 26191186
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.
Sinreih M; Hevir N; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):210-7. PubMed ID: 23200943
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
Chung TK; Cheung TH; Huen NY; Wong KW; Lo KW; Yim SF; Siu NS; Wong YM; Tsang PT; Pang MW; Yu MY; To KF; Mok SC; Wang VW; Li C; Cheung AY; Doran G; Birrer MJ; Smith DI; Wong YF
Int J Cancer; 2009 Mar; 124(6):1358-65. PubMed ID: 19065659
[TBL] [Abstract][Full Text] [Related]
27. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
29. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Peluso JJ; Liu X; Saunders MM; Claffey KP; Phoenix K
J Clin Endocrinol Metab; 2008 May; 93(5):1592-9. PubMed ID: 18319313
[TBL] [Abstract][Full Text] [Related]
30. [Amplification and expression of HER-2 oncogene in precancerous stages and cancers of the endometrium].
Czerwenka KF; Heuss F; Zeillinger R; Hosmann JW; Wagner T; Manavi M; Jelincic D; Lu Y; Kubista E
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():287-8. PubMed ID: 7906978
[No Abstract] [Full Text] [Related]
31. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
32. Spatiotemporal expression pattern of Progesterone Receptor Component (PGRMC) 1 in endometrium from patients with or without endometriosis or adenomyosis.
Thieffry C; Van Wynendaele M; Samain L; Tyteca D; Pierreux C; Marbaix E; Henriet P
J Steroid Biochem Mol Biol; 2022 Oct; 223():106153. PubMed ID: 35835350
[TBL] [Abstract][Full Text] [Related]
33. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
34. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
35. Progesterone-Induced miR-152 Inhibits the Proliferation of Endometrial Epithelial Cells by Downregulating WNT-1.
Nie L; Zhao YB; Pan JL; Lei Y; Liu M; Long Y; Zhang JH; Hu Y; Xu MQ; Yuan DZ; Yue LM
Reprod Sci; 2017 Oct; 24(10):1444-1453. PubMed ID: 28122483
[TBL] [Abstract][Full Text] [Related]
36. miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells.
Li S; Hu R; Wang C; Guo F; Li X; Wang S
Mol Med Rep; 2014 Jun; 9(6):2393-9. PubMed ID: 24715036
[TBL] [Abstract][Full Text] [Related]
37. Conditional Ablation of Progesterone Receptor Membrane Component 1 Results in Subfertility in the Female and Development of Endometrial Cysts.
McCallum ML; Pru CA; Niikura Y; Yee SP; Lydon JP; Peluso JJ; Pru JK
Endocrinology; 2016 Sep; 157(9):3309-19. PubMed ID: 27309940
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SNHG8 participates in the development of endometrial carcinoma through regulating c-MET expression by miR-152.
Yang CH; Zhang XY; Zhou LN; Wan Y; Song LL; Gu WL; Liu R; Ma YN; Meng HR; Tian YL; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1629-1637. PubMed ID: 29630089
[TBL] [Abstract][Full Text] [Related]
40. MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer.
Jeong O; Broaddus RR; Lessey BA; Risinger JI; Hunter MI; Kim TH
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]